Follow
Global Trial Accelerators™
Accelerate Your Path from First-in-Human to Exit
Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), Global Trial Accelerators™ is a clinical trials podcast for life-sciences founders and innovators in MedTech, Biotech/Biopharma, and Radiopharma, focused on first-in-human (FIH) and early feasibility studies. The show is produced by bioaccess® and was founded by Co-Founder & CEO Julio G. Martinez-Clark.
bioaccess® is a CRO purpose-built for first-in-human (FIH) trials, serving MedTech, Biopharma, and Radiopharma startups. This podcast delivers strategies, regulatory insights, and founder stories to get your technology into humans faster and affordably, with data designed to support FDA and EMA submissions.
Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and founders who have compressed timelines, reduced costs, and generated the clinical evidence investors demand by drawing on on-demand clinical research capability across the Americas.
What You'll Learn:
- Regulatory pathways across Latin America (Colombia, Mexico, Brazil, Chile, Argentina, Panama, Ecuador, El Salvador, Dominican Republic, Paraguay, and more)
- Why ethics approval in 4–8 weeks (vs. 6–12 months in the US/EU) changes the game for startups
- Strategies to generate FIH data that unlocks your next funding round or acquisition
- The Innovation Runway: from prototype to clinical milestones before capital runs out
- Lessons from more than 130 episodes with leaders from seed-stage startups to Fortune 500 MedTech companies
- Decentralized trials, AI-driven recruitment, and post-trial commercialization
Subscribe to unlock your shortcut from first-in-human to exit.
Brought to you by bioaccess®, an FIH-dedicated CRO for healthcare startups. Faster timelines, lower costs. Since 2010.
Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), Global Trial Accelerators™ is a clinical trials podcast for life-sciences founders and innovators in MedTech, Biotech/Biopharma, and Radiopharma, focused on first-in-human (FIH) and early feasibility studies. The show is produced by bioaccess® and was founded by Co-Founder & CEO Julio G. Martinez-Clark.
bioaccess® is a CRO purpose-built for first-in-human (FIH) trials, serving MedTech, Biopharma, and Radiopharma startups. This podcast delivers strategies, regulatory insights, and founder stories to get your technology into humans faster and affordably, with data designed to support FDA and EMA submissions.
Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and founders who have compressed timelines, reduced costs, and generated the clinical evidence investors demand by drawing on on-demand clinical research capability across the Americas.
What You'll Learn:
- Regulatory pathways across Latin America (Colombia, Mexico, Brazil, Chile, Argentina, Panama, Ecuador, El Salvador, Dominican Republic, Paraguay, and more)
- Why ethics approval in 4–8 weeks (vs. 6–12 months in the US/EU) changes the game for startups
- Strategies to generate FIH data that unlocks your next funding round or acquisition
- The Innovation Runway: from prototype to clinical milestones before capital runs out
- Lessons from more than 130 episodes with leaders from seed-stage startups to Fortune 500 MedTech companies
- Decentralized trials, AI-driven recruitment, and post-trial commercialization
Subscribe to unlock your shortcut from first-in-human to exit.
Brought to you by bioaccess®, an FIH-dedicated CRO for healthcare startups. Faster timelines, lower costs. Since 2010.
